Today: 31 January 2026
Subscribe
Browse Category

NASDAQ:ABBV News 30 January 2026

AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

New York, Jan 30, 2026, 14:47 EST — Regular session AbbVie shares climbed roughly 1% on Friday, closing in on the session peak at $222.73 after fluctuating between $219.54 and $222.77. The drugmaker plans to release its full-year and Q4 2025 results on Feb. 4 before the market opens, with a webcast set for 8 a.m. Central time. Investors expect…
30 January 2026
·····

Stock Market Today

  • Barclays Shares Surge 68% in Year as Valuation Nears Fair Value
    January 30, 2026, 11:41 PM EST. Barclays (LSE:BARC) posted £26 billion revenue and £5.9 billion net income, spurring a 68.05% total shareholder return over the past year. Shares trade at £4.86, close to a fair value estimate of £4.92, suggesting the recent rally remains within valuation bounds. Key growth drivers include digital banking investments and client expansion, while strategic cost controls and tech upgrades improve earnings quality. However, risks linger from potential deposit instability, credit quality declines, and competition pressures that could weigh on margins. Investors are weighing if the roughly 45% intrinsic discount provides a buying opportunity or reflects growth expectations already priced in. Barclays' outlook balances steady revenue expansion with cautious risk factors in the financial sector.
Go toTop